Pharmacological prospects for α2-adrenoceptor antagonist therapy
- 1 January 1992
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 13 (7) , 277-282
- https://doi.org/10.1016/0165-6147(92)90085-k
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Clonidine-displacing substance (CDS) and its putative imidazoline receptor: New leads for further divergence of α2-adrenergic receptor activityBiochemical Pharmacology, 1991
- Alpha-adrenoceptors: A critical reviewMedicinal Research Reviews, 1989
- Effect of Yohimbine Hydrochloride on Erectile Impotence: A Double-Blind StudyJournal of Urology, 1989
- Cloning, Sequencing, and Expression of the Gene Coding for the Human Platelet α 2 -Adrenergic ReceptorScience, 1987
- Postjunctional α2‐adrenoceptors mediate venoconstriction in the hindquarters circulation of anaesthetized catsBritish Journal of Pharmacology, 1987
- Pharmacological profile of a new potent and specific ?2-adrenoceptor antagonist, L-657,743Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1987
- α2-receptor control over release of noradrenaline in rat thalamusEuropean Journal of Pharmacology, 1986
- Comparison of the ?-adrenoceptor antagonist profiles of idazoxan (RX 781094), yohimbine, rauwolscine and corynanthineNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1984
- Physiological and pharmacological aspects of adrenergic receptor classificationBiochemical Pharmacology, 1983
- Characterization of physiological agonist selectivity of human fat cell α2-adrenoceptors: Adrenaline is the major stimulant of the α2-adrenoceptorsEuropean Journal of Pharmacology, 1982